YU27499A - Upotreba derivata 7-(2-oksa-5,8-diazabiciklo/4.3.0/non-8-il) -hinolin-karbonske kiseline za pripremanje farmaceutske kompozicije za tretiranje helikobakter-pilori infekcija i sa time povezanih gastroduodenskim oboljenjima - Google Patents
Upotreba derivata 7-(2-oksa-5,8-diazabiciklo/4.3.0/non-8-il) -hinolin-karbonske kiseline za pripremanje farmaceutske kompozicije za tretiranje helikobakter-pilori infekcija i sa time povezanih gastroduodenskim oboljenjimaInfo
- Publication number
- YU27499A YU27499A YU27499A YU27499A YU27499A YU 27499 A YU27499 A YU 27499A YU 27499 A YU27499 A YU 27499A YU 27499 A YU27499 A YU 27499A YU 27499 A YU27499 A YU 27499A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- quinolone
- oxa
- diazabicyclo
- substituted
- carboxylic acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines having two or more nitrogen atoms in the same ring, e.g. oxadiazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Pronalazak se odnosi na pripremanje derivata hinolon- i nafthiridon-karbonske kiseline, koji su u 7-položaju supstituisani sa 2-oksa-5,8- diazabiciklo[4.3.0]bib-8-il ostatkom, opšte formule (I) u kojoj oznake, A, R1, R2, R4 i R6 imaju značenja navedena u opisu, kao i njihovih hidrata i/ili soli, na primenu pomenutih jedinjenja za pripremanje farmaceutskih kompozicija za tretiranje helikobakter-pilori infekcija i sa time povezanih gastroduodenskih oboljenja.[The invention relates to the use of quinolone and naphthyridon carboxylic acid derivatives, which are substituted by a 2-oxa-5,8- diazabicyclo[4.3.0]-non-8-yl-radical in position seven, as well as to their pharmaceutically applicable hydrates and/or salts in the treatment of Helicobacter pylori infections and associated gastroduodenal diseases.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19652239A DE19652239A1 (de) | 1996-12-16 | 1996-12-16 | Verwendung von 7-(2-Oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-chinolon- und -naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen |
Publications (2)
Publication Number | Publication Date |
---|---|
YU27499A true YU27499A (sh) | 2002-10-18 |
RS49684B RS49684B (sr) | 2007-11-15 |
Family
ID=7814837
Country Status (28)
Country | Link |
---|---|
US (2) | US6133260A (sh) |
EP (1) | EP0946176B1 (sh) |
JP (3) | JP3463939B2 (sh) |
KR (1) | KR100536153B1 (sh) |
CN (1) | CN100335054C (sh) |
AT (1) | ATE214929T1 (sh) |
AU (1) | AU717751B2 (sh) |
BG (1) | BG64615B1 (sh) |
BR (1) | BR9714032A (sh) |
CA (1) | CA2274894C (sh) |
CZ (2) | CZ297363B6 (sh) |
DE (2) | DE19652239A1 (sh) |
DK (1) | DK0946176T3 (sh) |
EA (1) | EA002477B1 (sh) |
EE (1) | EE04090B1 (sh) |
ES (1) | ES2175519T3 (sh) |
HK (1) | HK1025517A1 (sh) |
HU (1) | HU226523B1 (sh) |
IL (1) | IL130311A (sh) |
NO (1) | NO325617B1 (sh) |
NZ (2) | NZ336228A (sh) |
PL (1) | PL191193B1 (sh) |
PT (1) | PT946176E (sh) |
RS (1) | RS49684B (sh) |
SK (2) | SK283224B6 (sh) |
TR (1) | TR199901754T2 (sh) |
UA (1) | UA57055C2 (sh) |
WO (1) | WO1998026779A1 (sh) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19633805A1 (de) * | 1996-02-23 | 1997-08-28 | Bayer Ag | Gegenenenfalls substituierte 8-Cyan-l-cyclopropyl-7-(2,8-diazabicyclo-[4.3.0]-nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäuren und ihre Derivate |
WO2000029369A1 (fr) * | 1998-11-18 | 2000-05-25 | Asahi Glass Company Ltd. | Derives d'acide aminoacrylique et procede de production correspondant |
DE19917617A1 (de) * | 1999-04-19 | 2000-10-26 | Bayer Ag | -(-)Enantiomeres des 2-[2-(1-Chlor-cyclopropyl)-3-(2-chlorphenyl) 2-hydroxy-propyl]-2,4-dihydro-[1,2,4]-triazol-3-thions |
WO2001002390A1 (fr) * | 1999-07-01 | 2001-01-11 | Wakunaga Pharmaceutical Co., Ltd. | Derive d'acide quinolinecarboxylique et ses sels |
PE20010635A1 (es) * | 1999-10-08 | 2001-08-15 | Smithkline Beecham Corp | Inhibidores de fab i utiles para el tratamiento de infecciones bacterianas |
CA2444597A1 (en) * | 2001-04-06 | 2002-10-06 | Affinium Pharmaceuticals, Inc. | Fab i inhibitors |
US7790709B2 (en) | 2002-12-06 | 2010-09-07 | Affinium Pharmaceuticals, Inc. | Heterocyclic compounds, methods of making them and their use in therapy |
WO2004082586A2 (en) | 2003-03-17 | 2004-09-30 | Affinium Pharmaceuticals, Inc. | Phamaceutical compositions comprising inhibitors of fab i and further antibiotics |
US7723524B2 (en) | 2003-09-29 | 2010-05-25 | Daiichi Pharmaceutical Co., Ltd. | 8-cyanoquinolonecarboxylic acid derivative |
CN1244582C (zh) * | 2004-04-21 | 2006-03-08 | 中国医学科学院医药生物技术研究所 | 喹诺酮羧酸类化合物及其制备方法和医药用途 |
US7759362B2 (en) | 2004-04-21 | 2010-07-20 | Institut Of Medicinal Biotechnology Chinese Academy Of Medical Sciences | Quinolonecarboxylic acid compounds, preparation methods and pharmaceutical uses thereof |
EP2848614A3 (en) * | 2004-06-04 | 2015-07-29 | Debiopharm International SA | Acrylamide derivatives as antibiotic agents |
JP2009518399A (ja) * | 2005-12-05 | 2009-05-07 | アフィニウム ファーマシューティカルズ, インク. | Fabi阻害剤および抗菌剤としてのヘテロ環アクリルアミド化合物 |
WO2008009122A1 (en) | 2006-07-20 | 2008-01-24 | Affinium Pharmaceuticals, Inc. | Acrylamide derivatives as fab i inhibitors |
WO2008098374A1 (en) * | 2007-02-16 | 2008-08-21 | Affinium Pharmaceuticals, Inc. | Salts, prodrugs and polymorphs of fab i inhibitors |
AU2010266120B2 (en) | 2009-07-02 | 2014-02-06 | Curofin Pharma Gmbh | Compositions comprising finafloxacin and methods for treating ophthalmic, otic, or nasal infections |
RU2449805C1 (ru) | 2011-01-27 | 2012-05-10 | Общество С Ограниченной Ответственностью "Гармония" | Пептидная фармацевтическая композиция, средство на ее основе для лечения гастродуоденальных заболеваний, вызываемых helicobacter pylori, и способ его использования |
AU2013279021C1 (en) | 2012-06-19 | 2017-03-16 | Debiopharm International Sa | Prodrug derivatives of (E)-N-methyl-N-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide |
US9504691B2 (en) * | 2012-12-06 | 2016-11-29 | Alcon Research, Ltd. | Finafloxacin suspension compositions |
JP2016527322A (ja) | 2013-08-12 | 2016-09-08 | ノバルティス アーゲー | 鼓膜チューブ配置後の耳感染症の治療方法 |
DE102014115951A1 (de) * | 2014-11-03 | 2016-05-04 | Merlion Pharmaceuticals Pte Ltd. | Zusammensetzungen, die Finafloxacin und Tris enthalten |
DE102015100068A1 (de) | 2015-01-06 | 2016-07-07 | Merlion Pharmaceuticals Pte Ltd. | Finafloxacin zur verwendung bei der behandlung von harnwegsinfektionen |
KR20180114177A (ko) | 2016-02-26 | 2018-10-17 | 데비오팜 인터네셔날 에스 에이 | 당뇨병성 족부 감염의 치료제 |
CN107987074B (zh) * | 2017-10-27 | 2020-12-29 | 浙江美诺华药物化学有限公司 | 一种普拉沙星的合成方法 |
MX2020011280A (es) * | 2018-04-25 | 2020-11-13 | Bayer Animal Health Gmbh | Proceso para la hidrolisis de esteres carboxilicos de quinolona. |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4822801A (en) * | 1984-07-20 | 1989-04-18 | Warner-Lambert Company | 4-oxo-1,4-dihydroquinoline-3-carboxylic acid derivative as antibacterial agents |
JPS62205060A (ja) * | 1986-03-04 | 1987-09-09 | Kyorin Pharmaceut Co Ltd | 8位置換キノロンカルボン酸誘導体 |
DE3702393A1 (de) * | 1987-01-28 | 1988-08-11 | Bayer Ag | 8-cyano-1-cyclopropyl-1,4-dihydro-4-oxo- 3-chinolincarbonsaeuren, verfahren zu ihrer herstellung und diese enthaltende antibakterielle mittel |
US5563138A (en) * | 1987-04-16 | 1996-10-08 | Otsuka Pharmaceutical Company, Limited | Benzoheterocyclic compounds |
US4889857A (en) * | 1987-10-12 | 1989-12-26 | Yoshitomi Pharmaceutical Industries, Ltd. | Quinolonecarboxylic acid compounds and pharmaceutical use thereof |
WO1989005643A1 (en) * | 1987-12-18 | 1989-06-29 | Pfizer Inc. | Heterocyclic-substituted quinoline-carboxylic acids |
JP2844079B2 (ja) * | 1988-05-23 | 1999-01-06 | 塩野義製薬株式会社 | ピリドンカルボン酸系抗菌剤 |
DE3906365A1 (de) * | 1988-07-15 | 1990-01-18 | Bayer Ag | 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe |
US5147873A (en) * | 1988-08-23 | 1992-09-15 | Pfizer Inc. | Amino-substituted bridged azabicyclic quinolone carboxylic acids and esters |
CA2001203C (en) * | 1988-10-24 | 2001-02-13 | Thomas P. Demuth, Jr. | Novel antimicrobial dithiocarbamoyl quinolones |
US5262417A (en) * | 1988-12-06 | 1993-11-16 | The Upjohn Company | Antibacterial quinolone compounds |
US5407932A (en) * | 1989-03-31 | 1995-04-18 | Wakunaga Seiyaku Kabushiki Kaisha | Quinolone derivatives and antibacterial agents containing the same |
DE3910663A1 (de) * | 1989-04-03 | 1990-10-04 | Bayer Ag | 5-alkylchinoloncarbonsaeuren |
US5140033A (en) * | 1989-04-03 | 1992-08-18 | Bayer Aktiengesellschaft | Antibacterial 5-alkylquinolonecarboxylic acids |
US5252734A (en) * | 1989-04-03 | 1993-10-12 | Bayer Aktiengesellschaft | Antibacterial 5-alkylquinolonecarboxylic acids |
US5164402A (en) * | 1989-08-16 | 1992-11-17 | Pfizer Inc | Azabicyclo quinolone and naphthyridinone carboxylic acids |
KR910009330B1 (ko) * | 1989-10-23 | 1991-11-11 | 재단법인 한국화학연구소 | 항균작용을 갖는 퀴놀린계 화합물과 그의 제조방법 |
TW209865B (sh) * | 1992-01-10 | 1993-07-21 | Bayer Ag | |
DE4200415A1 (de) | 1992-01-10 | 1993-07-15 | Bayer Ag | Enantiomerenreine 2-oxa-5,8-diazabicyclo(4.3.0)nonane sowie verfahren zu ihrer herstellung |
CA2112165C (en) * | 1992-12-25 | 2003-04-08 | Makoto Takemura | Bicyclic amine derivatives |
DE4309964A1 (de) | 1993-03-26 | 1994-09-29 | Bayer Ag | Verfahren zur Herstellung enantiomerenreiner trans-2-Oxa-5,8-diazabicyclo[4.3.0]nonane |
AU4272793A (en) * | 1993-04-24 | 1994-11-21 | Korea Research Institute Of Chemical Technology | Novel quinolone carboxylic acid derivatives and process for preparing the same |
US5532239A (en) * | 1993-08-02 | 1996-07-02 | Assistance Publique - Hopitaux De Paris | Therapeutic application of fluoroquinolone derivatives |
DE4329600A1 (de) * | 1993-09-02 | 1995-03-09 | Bayer Ag | Pyrido [1,2,3-d,e] [1,3,4] benzoxadiazinderivate |
ATE170400T1 (de) * | 1994-04-07 | 1998-09-15 | Pfizer | Verwendung von trovafloxacin oder dessen derivaten zur herstellung eines arzneimittels zur behandlung von h.pylori infektionen |
GB2289674A (en) * | 1994-05-23 | 1995-11-29 | Pfizer | Antibacterial naphthyridine |
JPH0848629A (ja) * | 1994-08-08 | 1996-02-20 | Dainippon Pharmaceut Co Ltd | ピリドンカルボン酸誘導体およびそれを有効成分とする抗ピロリ菌剤 |
-
1996
- 1996-12-16 DE DE19652239A patent/DE19652239A1/de not_active Withdrawn
-
1997
- 1997-04-12 UA UA99074093A patent/UA57055C2/uk unknown
- 1997-12-04 TR TR1999/01754T patent/TR199901754T2/xx unknown
- 1997-12-04 AU AU58541/98A patent/AU717751B2/en not_active Expired
- 1997-12-04 EE EEP199900248A patent/EE04090B1/xx unknown
- 1997-12-04 JP JP52725098A patent/JP3463939B2/ja not_active Expired - Lifetime
- 1997-12-04 RS YUP-274/99A patent/RS49684B/sr unknown
- 1997-12-04 AT AT97954354T patent/ATE214929T1/de active
- 1997-12-04 KR KR10-1999-7005330A patent/KR100536153B1/ko not_active IP Right Cessation
- 1997-12-04 DE DE59706808T patent/DE59706808D1/de not_active Expired - Lifetime
- 1997-12-04 PT PT97954354T patent/PT946176E/pt unknown
- 1997-12-04 SK SK1496-2000A patent/SK283224B6/sk not_active IP Right Cessation
- 1997-12-04 WO PCT/EP1997/006781 patent/WO1998026779A1/de active IP Right Grant
- 1997-12-04 CN CNB971817200A patent/CN100335054C/zh not_active Expired - Lifetime
- 1997-12-04 SK SK795-99A patent/SK283223B6/sk not_active IP Right Cessation
- 1997-12-04 NZ NZ336228A patent/NZ336228A/xx not_active IP Right Cessation
- 1997-12-04 EA EA199900526A patent/EA002477B1/ru not_active IP Right Cessation
- 1997-12-04 US US09/319,888 patent/US6133260A/en not_active Expired - Lifetime
- 1997-12-04 IL IL13031197A patent/IL130311A/en not_active IP Right Cessation
- 1997-12-04 BR BR9714032-5A patent/BR9714032A/pt not_active IP Right Cessation
- 1997-12-04 PL PL333928A patent/PL191193B1/pl unknown
- 1997-12-04 CA CA002274894A patent/CA2274894C/en not_active Expired - Lifetime
- 1997-12-04 HU HU0000450A patent/HU226523B1/hu unknown
- 1997-12-04 CZ CZ0216899A patent/CZ297363B6/cs not_active IP Right Cessation
- 1997-12-04 DK DK97954354T patent/DK0946176T3/da active
- 1997-12-04 CZ CZ20003148A patent/CZ297364B6/cs not_active IP Right Cessation
- 1997-12-04 EP EP97954354A patent/EP0946176B1/de not_active Expired - Lifetime
- 1997-12-04 ES ES97954354T patent/ES2175519T3/es not_active Expired - Lifetime
-
1999
- 1999-06-08 BG BG103474A patent/BG64615B1/bg unknown
- 1999-06-14 NO NO19992903A patent/NO325617B1/no not_active IP Right Cessation
- 1999-11-08 US US09/436,316 patent/US6432948B1/en not_active Expired - Lifetime
-
2000
- 2000-05-25 JP JP2000154543A patent/JP4463380B2/ja not_active Expired - Lifetime
- 2000-08-04 NZ NZ506162A patent/NZ506162A/en not_active IP Right Cessation
- 2000-08-04 HK HK00104882A patent/HK1025517A1/xx not_active IP Right Cessation
-
2009
- 2009-07-22 JP JP2009171127A patent/JP5112395B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU27499A (sh) | Upotreba derivata 7-(2-oksa-5,8-diazabiciklo/4.3.0/non-8-il) -hinolin-karbonske kiseline za pripremanje farmaceutske kompozicije za tretiranje helikobakter-pilori infekcija i sa time povezanih gastroduodenskim oboljenjima | |
BG103945A (en) | Derivatives of 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a | |
BG106095A (en) | Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics | |
NO940789L (no) | Quinolinkarboksylsyrederivater, deres fremstilling og anvendelse | |
PL361341A1 (en) | Novel pharmaceutical composition | |
WO1999047497A3 (en) | Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment | |
LU90856I2 (fr) | Uprima - apomorphine hydrochloride et ses d-riv-s pharmaceutiquement acceptables | |
EP0807633A3 (en) | Novel 2,3-disubstituted-(5,6)- heteroarylfused-pyrimidine-4-ones | |
GR3019796T3 (en) | Quinolone carboxylic acid derivatives, process for their preparation and their use | |
NO980380D0 (no) | Karbapenem antibiotika, preparat og fremstillingsmetode | |
EP1152762B8 (de) | Verwendung von desoxypeganin zur behandlung von alzheimerischer demenz | |
MY133169A (en) | Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect | |
AU5853898A (en) | Use of 7-(1-aminomethyl-2-oxa-7-aza-bicyclo{3.3.0}oct-7-yl)-quinolo ne carboxylic acid and naphthyridone carboxylic acid derivatives for treating (helicobacter pylori) infections and the gastroduodenal diseases associated therewith | |
HK1007857A1 (en) | New compound leustroducsin H its preparation and its therapeutic use | |
GR3035489T3 (en) | Quinolone and naphthyridone carboxylic acid derivatives | |
TW343973B (en) | Morphinan derivative and medical use | |
MX9603713A (es) | Composicion farmaceutica sublingual o bucal. |